The first event was held at Nasdaq in Stockholm March 8-9, 2017. The next event is being planned to the beginning of 2018, also in Stockholm. With a few modifications, the format will follow the success of first vc2vc. During the spring 2018 we are also planning for a trip toBoston. The idea will be that the Nordic investors will meet investors from greater Boston and from the area around Toronto and Montreal. The details of these events will appear shortly.
Vc2vc connects Nordic VC with foreign VC in the area of Life Science. In this meeting there are no biotech companies present, only VCs. The meeting includes partnering opportunities and a few presentations. It’ held in Stockholm, from lunch to lunch on March 8-9, 2017. The goal is to get Nordic VC to syndicate with foreign investors and thereby exposing the Nordic Life sector to foreign capital. We expect that syndication with Nordic VCs is a good way to get to know the Life Science sector in the Nordic countries, with the result of lowering the threshold for investments in the region.
During vc2vc 2017, 16 VC companies from the Nordic countries were present, representing some 350 companies.